By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tesaro, Inc. 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Tesaro, Inc. (TSRO) Appoints Jeffrey H. Hanke, Ph.D., As Executive Vice President, Research & Development, And Chief Scientific Officer 6/29/2015 7:37:39 AM
Tesaro, Inc. (TSRO) Announces Successful Completion Of Rolapitant Bioequivalence Study 6/1/2015 10:48:39 AM
Tesaro, Inc. (TSRO) And Merck & Co. (MRK) To Collaborate On A Combination Study Of Niraparib And KEYTRUDA (Pembrolizumab) 6/1/2015 7:36:04 AM
Tesaro, Inc. (TSRO) Announces Webcast Of Presentation At The Jefferies and Co. 2015 Global Healthcare Conference 5/20/2015 1:59:32 PM
Tesaro, Inc. (TSRO) Announces Seven Abstracts To Be Presented At The 2015 ASCO Annual Meeting 5/14/2015 1:01:33 PM
Tesaro, Inc. (TSRO) Announces Election Of Garry A. Nicholson To Board Of Directors And Results Of Annual Stockholder Meeting 5/14/2015 10:45:28 AM
Tesaro, Inc. (TSRO) Announces Election Of Garry A. Nicholson To Board Of Directors And Results Of Annual Stockholder Meeting 5/14/2015 9:59:36 AM
Tesaro, Inc. (TSRO) Release: 2015 ASCO Annual Meeting Investor Briefing 5/11/2015 11:20:57 AM
Tesaro, Inc. (TSRO) Announces First-Quarter 2015 Operating Results 5/1/2015 8:36:33 AM
Tesaro, Inc. (TSRO) Announces Completion Of Targeted Enrollment In Phase III NOVA Trial And Initiation Of The QUADRA Trial Of Niraparib 5/1/2015 7:27:51 AM
12345678
//-->